Cologne, Germany / Basel, Switzerland – Lonza now offers a comprehensive portfolio of fresh and cryopreserved human and animal hepatocytes for ADME-Tox testing, further strengthening its position as a leader in cell discovery. This expansion of Lonza’s primary cells range is the result of last year’s acquisition of renowned hepatocyte provider, Triangle Research Laboratories (TRL). By […]
The IntelliCyt Cy-Clone™ PLUS Assay System will accelerate and improve the quality of clone ranking and selection for developing cell lines which can reduce production costs of biopharmaceuticals. Albuquerque, New Mexico IntelliCyt, a Sartorius Company, and a leading provider of integrated platforms that accelerate drug discovery, antibody screening and immuno-oncology research today announced the launch […]
Validated for human identification, the system drives efficiencies and positions casework laboratories for future advancements CARLSBAD, Calif.–Forensic scientists who want to modernize their laboratories now have access to the Applied Biosystems QuantStudio 5 Real-Time PCR System for Human Identification. Paired with the complementary analysis software and Thermo Fisher Scientific’s leading DNA chemistries, the complete solution […]
Leading Experts in Genomic Medicine and Cancer Research are Inaugural Members CAMBRIDGE, Mass. – Seven Bridges, the biomedical data analysis company, today announced its Scientific Advisory Board, which formalizes relationships with leading global experts in genomic medicine, bioinformatics and cancer research. Members of the Seven Bridges Scientific Advisory Board will advise on the company’s product designs […]
AUSTIN, Texas − Asuragen, Inc., a global molecular diagnostics company, announced today the availability of the AmplideX® PCR/CE TOMM40 Kit1 for research use only to advance studies of neurodegeneration, dementia progression, and Alzheimer’s disease (AD). AD is the most common cause of dementia worldwide with over 46 million people now living with the disease. These numbers are expected to increase dramatically over […]
Financing to Drive Commercialization of Next Generation Biotechnology Instrumentation for Drug Discovery and Development BURLINGTON, MA RedShift BioAnalytics, Inc., an innovative provider of bioanalytical instrumentation for the research, development and manufacturing of protein therapeutic drugs, today announced the closing of the Company’s $11.0 million Series C Preferred Stock financing. The financing was co-led by Waters […]
Today we announced the launch of the GridION X5, a new system that can drive up to five MinION Flow Cells and process all the data produced within a single benchtop device. GridION X5 can be used to offer nanopore sequencing as a service. Why GridION X5? Recent releases for the portable MinION device, such […]
MR Solutions’ new 9.4 tesla cryogen free preclinical scanners created great interest from cardiologists at the 20th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR). As well as being extremely powerful this new scanner can be multi-modality, incorporating PET and/or SPECT capabilities. MR Solutions’ helium free scanners offer a compact scanner with a […]
VANCOUVER, British Columbia — LexaGene Holdings Inc. (TSX-V:LXG) (the “Company”). LexaGene is pleased to announce that the Company has started trading on the OTCQB Venture Market in the United States under the symbol LXXGF. The OTCQB is equivalent in Canada to the TSX Venture Exchange for early-stage and developing companies. Lexagene is also pleased to […]
Sophia Genetics reports adoption of its AI SOPHiA by over 250 health institutions in 45 countries By the end of Q1 2017, the company will cross the strategic threshold of 100K patients’ genomic profiles analyzed by its artificial intelligence Strategic milestones underline SOPHiA’s traction and confirm it is now clinicians’ technology of choice for analyzing […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
